Bladder Cancer Breakthroughs

Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination. Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer‑review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs. Dr. Abdullah AlAsmari was graduated from King Saud University (KSU) with a B.S. in Pharmaceutical Sciences in 2011. In 2013, Dr. AlAsmari joined Auburn University (AU), Harrison School of Pharmacy department of Drug Discovery and Development (DDD) to pursue his PhD under supervision of Dr. Jianzhong Shen and Dr. Amin. In 2017, Dr. AlAsmari returned to KSU with PhD degree and became an assistant professor in the department of Pharmacology & Toxicology. Now he has been promoted as Associate Professor and serving as Vice Dean for Programs and Initiatives at Graduate School at KSU. He is currently working on different funded projects, which aim to induce cardioprotection against different mechanisms that can induce cardiac damage. His research area includes: Cardiovascular Diseases, Mechanisms of cardiotoxicity induced by different anti-cancer drugs. Dr Abdullah has published more than 150 articles in different reputed and peer reviewed journals and several book chapters.

• 1. Epidemiology and risk factors of bladder cancer2. Diagnosis approaches for bladder cancer3. Role of hydrogel in bladder cancer treatment4. Role of Nanoparticles in bladder cancer management5. Role of Quantum dots in bladder cancer management6. Nanomaterial based biomarkers in bladder cancer management7. Role of nanorods in bladder cancer management8. Role of liposomes in bladder cancer management9. Role of artificial intelligence in bladder cancer management10. Role of nanocomposite for bladder cancer management11. Targeting treatment of bladder cancer employing aptamer conjugates12. Surgical interventions for bladder cancer management13. Image guided radiotherapy for bladder cancer management14. Role of gene sequencing in bladder cancer15. Addressing and overcoming resistance in bladder cancer treatment